MAP2K7 and leukemia: Treatment with the pan-PI3K inhibitor GDC-0941 alone and in combination with the MEK inhibitor PD0325901 (PD901) markedly extended the survival of recipient mice transplanted with KrasWT and KrasG12D T-ALLs [20], but these leukemias invariably relapsed despite continuous drug administration.